Back
Vericel Vs. Karyopharm Therapeutics Industry Stock Comparison
Buy
58
VCEL
Vericel
Last Price:
48.04
Seasonality Move:
2.13%
Buy
54
KPTI
Karyopharm Therapeutics
Last Price:
1.09
Seasonality Move:
-3.19%
Buy
58
Vericel (VCEL)
is a Buy
Is Vericel a Buy, Sell or Hold?
- The current Vericel [VCEL] share price is $48.10. The Score for VCEL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VCEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Karyopharm Therapeutics (KPTI)
is a Buy
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.09. The Score for KPTI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- KPTI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCEL Stock Price Chart
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing buying pressure, which is a positive indicator for future bullish movement.
VCEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 52.64 | Buy |
| Chaikin Money Flow: | -105238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.58 - 48.98) | Buy |
| Bollinger Bands (100): | (39.25 - 49.33) | Buy |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 45.04 | Sell |
| Chaikin Money Flow: | 627727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.26) | Sell |
| Bollinger Bands (100): | (0.9 - 1.4) | Sell |
VCEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.97 | Buy |
| 20-day SMA: | 46.79 | Buy |
| 50-day SMA: | 47.22 | Buy |
| 200-day SMA: | 39.24 | Buy |
| 8-day EMA: | 47.87 | Buy |
| 20-day EMA: | 47.5 | Buy |
| 50-day EMA: | 46.82 | Buy |
| 200-day EMA: | 40.96 | Buy |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Sell |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 1.08 | Buy |
| 20-day EMA: | 1.13 | Sell |
| 50-day EMA: | 1.19 | Sell |
| 200-day EMA: | 1.44 | Sell |
Vericel Earnings Growth & VCEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.26 per share, and an increase next year of $0.40 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.34 per share.
Vericel Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||